NIH-funded research R01 grant

Understanding how Huntington disease disrupts protein production in brain cells

Official title: Mechanisms of Translational Dysregulation in Huntington Disease

Funded at Florida Atlantic University · NIH-11126038 · Data updated 2026-11-12

Researchers are studying Huntington disease to learn how a faulty protein blocks ribosomes and slows protein-making in brain cells, which may contribute to movement and thinking problems.

More Huntington Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionFlorida Atlantic University
NIH-funded
Lab location1 site (Boca Raton, United States)
Project startJuly 1, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$381,250
NIH project number5R01NS138278-03
Project IDNIH-11126038 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with Huntington disease or carriers with brain involvement who could contribute samples or be considered for future translational studies.

Less likely to help

People without Huntington disease or without involvement of ribosome dysfunction in HD would not directly benefit.

What this research studies

This project looks at why ribosomes stall during protein synthesis in brain cells affected by Huntington disease. Using advanced ribosome profiling and biochemical techniques, the team will map how mutant huntingtin interacts with RNA and ribosome-binding proteins to slow or stop production of other proteins. The study aims to connect molecular findings with the cognitive and motor symptoms seen in HD, potentially revealing new targets to slow disease progression. Results could inform future therapies that restore normal protein production in the brain.

Why it matters

Potential benefit: If successful, the work could identify new molecular targets to restore protein synthesis in HD, potentially slowing neurodegeneration and cognitive decline.

How similar studies have gone: Preliminary findings and prior work suggest ribosome interactions with mutant huntingtin are linked to impaired protein synthesis, supporting feasibility.

Where this research is happening

  • Florida Atlantic University
    Boca Raton, United States
    Active

Researchers

  • Principal investigator: Subramaniam, Srinivasa — Florida Atlantic University
  • Study coordinator: Subramaniam, Srinivasa

Related research

Other NIH-funded projects on the same topics.

  • Harnessing neuron-derived vesicles to find Huntington’s disease biomarkers

    A research project aims to identify brain-derived biomarkers in blood that reflect Huntington disease activity, using neuronal extracellular vesicles as the signal source.

    NIH research University of Central Florida · Orlando, United States · NIH-11448886

  • Understanding how blood flow problems in the brain affect Huntington’s disease

    A study at a major hospital is looking at how blood vessels in the brain may contribute to symptoms and brain changes in Huntington’s disease.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11371125

  • Rhes‑SUMO pathway's role in Huntington's disease

    This work looks at whether the Rhes‑SUMO protein system increases toxic huntingtin and helps it spread in the brain, which may explain early striatal damage in people with Huntington's disease.

    NIH research Florida Atlantic University · Boca Raton, United States · NIH-11299742

  • Understanding how ribosome stalling affects Huntington disease

    This study is looking at how a problem with protein production in the brain might contribute to Huntington disease, which could help us find new ways to treat the condition.

    NIH research Florida Atlantic University · Boca Raton, United States · NIH-11264540

  • Rhes-SUMO Pathway and Huntington Disease in Mice

    A study in mouse models explores how the Rhes-SUMO pathway may drive brain and nerve cell vulnerability in Huntington disease.

    NIH research Florida Atlantic University · Boca Raton, United States · NIH-11176921

  • Investigating the role of the Rhes-SUMO pathway in Huntington's disease

    This study is looking at how a specific pathway in the brain might affect the worsening of Huntington's disease, with the hope of finding new ways to help manage the symptoms and slow down the disease for those living with it.

    NIH research University of Florida · Gainesville, United States · NIH-11175740

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.